ERIC A. ADAMS - 08 Mar 2023 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
President & CEO, Director
Signature
/s/ Eric A Adamas
Issuer symbol
INM
Transactions as of
08 Mar 2023
Net transactions value
$0
Form type
4
Filing time
09 Mar 2023, 14:43:46 UTC
Previous filing
19 Dec 2022
Next filing
16 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -545 -1.9% $0.000000 27,957 08 Mar 2023 Common shares 545 $927.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$1,278.75 using an exchange rate of C$1.3785 = $US1.00